CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 214 filers reported holding CYTOKINETICS INC in Q3 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,960,799 | -13.0% | 66,558 | -3.7% | 0.00% | 0.0% |
| Q2 2023 | $2,254,270 | -1.3% | 69,107 | +6.4% | 0.00% | 0.0% |
| Q1 2023 | $2,284,852 | -17.3% | 64,929 | +7.5% | 0.00% | -50.0% |
| Q4 2022 | $2,763,206 | -5.1% | 60,383 | +0.9% | 0.00% | 0.0% |
| Q3 2022 | $2,912,280 | +24.7% | 59,839 | +10.2% | 0.00% | 0.0% |
| Q2 2022 | $2,335,014 | +18.2% | 54,280 | +0.8% | 0.00% | +100.0% |
| Q1 2022 | $1,975,523 | +8.4% | 53,831 | +34.6% | 0.00% | 0.0% |
| Q4 2021 | $1,823,000 | +25.4% | 39,985 | -1.7% | 0.00% | 0.0% |
| Q3 2021 | $1,454,000 | +89.6% | 40,694 | +5.0% | 0.00% | 0.0% |
| Q2 2021 | $767,000 | -12.6% | 38,753 | +2.7% | 0.00% | 0.0% |
| Q1 2021 | $878,000 | +5.5% | 37,744 | -5.7% | 0.00% | 0.0% |
| Q4 2020 | $832,000 | +1.8% | 40,030 | +6.0% | 0.00% | 0.0% |
| Q3 2020 | $817,000 | +3.3% | 37,750 | +12.5% | 0.00% | 0.0% |
| Q2 2020 | $791,000 | +85.2% | 33,551 | -7.3% | 0.00% | – |
| Q1 2020 | $427,000 | +17.6% | 36,200 | +5.7% | 0.00% | – |
| Q4 2019 | $363,000 | -9.9% | 34,241 | -3.1% | 0.00% | – |
| Q3 2019 | $403,000 | +1.5% | 35,331 | 0.0% | 0.00% | – |
| Q2 2019 | $397,000 | +55.7% | 35,331 | +12.5% | 0.00% | – |
| Q1 2019 | $255,000 | +34.9% | 31,401 | +4.7% | 0.00% | – |
| Q4 2018 | $189,000 | -41.5% | 29,989 | -8.6% | 0.00% | – |
| Q3 2018 | $323,000 | +3.2% | 32,817 | -12.7% | 0.00% | – |
| Q2 2018 | $313,000 | +32.1% | 37,582 | +14.2% | 0.00% | – |
| Q1 2018 | $237,000 | -13.2% | 32,907 | -1.9% | 0.00% | – |
| Q4 2017 | $273,000 | -42.3% | 33,559 | +2.9% | 0.00% | -100.0% |
| Q3 2017 | $473,000 | +19.7% | 32,615 | -0.3% | 0.00% | – |
| Q2 2017 | $395,000 | +12.5% | 32,708 | +20.2% | 0.00% | – |
| Q1 2017 | $351,000 | +19.4% | 27,218 | +12.6% | 0.00% | – |
| Q4 2016 | $294,000 | +30.7% | 24,176 | -1.6% | 0.00% | – |
| Q3 2016 | $225,000 | -7.8% | 24,578 | -4.3% | 0.00% | – |
| Q2 2016 | $244,000 | +48.8% | 25,695 | +5.2% | 0.00% | – |
| Q1 2016 | $164,000 | -37.9% | 24,433 | -3.5% | 0.00% | – |
| Q4 2015 | $264,000 | +56.2% | 25,313 | 0.0% | 0.00% | – |
| Q3 2015 | $169,000 | +2.4% | 25,313 | +3.1% | 0.00% | – |
| Q2 2015 | $165,000 | +2.5% | 24,548 | +3.2% | 0.00% | – |
| Q1 2015 | $161,000 | -19.9% | 23,793 | -5.3% | 0.00% | – |
| Q4 2014 | $201,000 | +145.1% | 25,123 | +7.4% | 0.00% | – |
| Q3 2014 | $82,000 | -26.1% | 23,393 | 0.0% | 0.00% | – |
| Q2 2014 | $111,000 | -44.2% | 23,393 | +11.6% | 0.00% | – |
| Q1 2014 | $199,000 | +42.1% | 20,969 | -2.4% | 0.00% | – |
| Q4 2013 | $140,000 | -2.1% | 21,494 | +13.8% | 0.00% | – |
| Q3 2013 | $143,000 | – | 18,894 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |